SHE:300294 Revenue

China Resources Boya Bio-pharmaceutical Group Co.,Ltd had revenue of 466.15M CNY in the quarter ending September 30, 2025, with 33.43% growth. This brings the company's revenue in the last twelve months to 1.96B, up 15.06% year-over-year. In the year 2024, China Resources Boya Bio-pharmaceutical Group Co.,Ltd had annual revenue of 1.73B, down -34.58%.

Revenue (ttm)

1.96B

Revenue Growth

+15.06%

P/S Ratio

5.91

Revenue / Employee

1.01M

Employees

1,938

Market Cap

11.60B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.73B	-917.08M	-34.58%
Dec 31, 2023	2.65B	-106.72M	-3.87%
Dec 31, 2022	2.76B	108.17M	4.08%
Dec 31, 2021	2.65B	137.49M	5.47%
Dec 31, 2020	2.51B	-395.73M	-13.60%
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2017	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2016	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong	16.62B
Youcare Pharmaceutical Group	2.55B
Jiangsu Sinopep-Allsino Biopharmaceutical	1.90B
Aurisco Pharmaceutical	1.62B
Vcanbio Cell & Gene Engineering Corp.,	1.47B
Liaoning Chengda Biotechnology	1.47B
Hualan Biological Vaccine	976.44M
Acrobiosystems	794.52M

Revenue Rankings